US10278951B1 – May 7, 2019 – Method of treating opiate dependency using tetrahydrocannabinol extracts

Please complete the required fields.




Inventors :

Jon Newland

Owner :

Newland, Jon

Application Number :

US15719851

Document Number :

US10278951B1

Priority Date :

September 29, 2017

Filing Date :

September 29, 2017

Date of Grant/ Publication :

May 7, 2019

Class :

; A61K9 / 00; A61K9 / 08; A61K47 / 10; A61K47 / 20; A61K31 / 352

Abstract

The present invention provides a method of orally treating opiate dependency in a patient in need thereof. The method includes: orally administering an aqueous composition including: tetrahydrocannabinol (THC); one or more aprotic solvents, for example, dimethyl sulfoxide; one or more protic solvents, for example ethanol; and water. Methods of orally reducing or preventing opiate withdrawal, orally reducing or preventing opiate withdrawal symptoms, orally treating post-surgical and chronic pain in a patient are also provided.

Claim(s)

1. A method of orally treating opiate dependency in a human in need thereof comprising; orally administering an aqueous composition consisting essentially of: tetrahydrocannabinol (THC); dimethyl sulfoxide (DMSO); ethanol; and water.;
7. A method of orally treating opiate dependency in a human in need thereof comprising; orally administering an aqueous composition consisting essentially of: tetrahydrocannabinol (THC); dimethyl sulfoxide (DMSO); ethanol; and water, and wherein the opiate dependency is caused by one or more opiate compounds each independently comprising oxycontin, hydrocodone, oxycodone, morphine, or a combination thereof.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login